Inscription Capital »

Cullinan Oncology shares owned by Inscription Capital

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Inscription Capital from 13F filings

Historical chart of Inscription Capital investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Inscription Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Inscription Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $121k 12k 10.35
2025-09-30 $67k 11k 5.93

More positions owned by Inscription Capital

Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Spdr Series Trust State Street Spd (BIL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Wal-Mart Stores (WMT)
Chevron Corporation (CVX)
Nike CL B (NKE)

View all positions for Inscription Capital

Top funds holding Cullinan Oncology

Lynx1 Capital Management
MPM Oncology Impact Management
BVF
BlackRock
Vanguard Group
Kynam Capital Management
Blue Owl Capital Holdings
State Street Corporation
Citadel Advisors
Affinity Asset Advisors
Rtw Investments
VR Adviser
Geode Capital Management
Boothbay Fund Management
Siren

View all funds holding Cullinan Oncology